HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated levels of the guanine nucleotide binding protein, Go, are associated with differentiation of neuroblastoma x glioma hybrid cells.

Abstract
Each of a range of pharmacological agents which function to increase intracellular levels of cAMP caused a morphological 'differentiation' of neuroblastoma x glioma hybrid, NG108-15, cells grown in tissue culture. Associated with this differentiation, increased incorporation of [32P]ADP-ribose catalysed by pertussis toxin was noted into a band of some 39-40 kDa in membranes derived from these cells. Immunoblotting using two antipeptide antisera which identify different regions of Go alpha demonstrated marked increases in the levels of this polypeptide in membranes of the differentiated cells. However, levels of the beta-subunit did not increase appreciably with differentiation.
AuthorsI Mullaney, G Milligan
JournalFEBS letters (FEBS Lett) Vol. 244 Issue 1 Pg. 113-8 (Feb 13 1989) ISSN: 0014-5793 [Print] England
PMID2538344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Virulence Factors, Bordetella
  • NAD
  • Colforsin
  • Adenosine Diphosphate Ribose
  • Bucladesine
  • Cyclic AMP
  • Pertussis Toxin
  • GTP-Binding Proteins
  • Alprostadil
Topics
  • Adenosine Diphosphate Ribose (metabolism)
  • Alprostadil (pharmacology)
  • Blotting, Western
  • Bucladesine (pharmacology)
  • Cell Differentiation
  • Cell Membrane (drug effects, metabolism)
  • Colforsin (pharmacology)
  • Cyclic AMP (metabolism)
  • Electrophoresis, Polyacrylamide Gel
  • GTP-Binding Proteins (metabolism)
  • Glioma (metabolism)
  • Hybrid Cells (metabolism)
  • Molecular Weight
  • NAD (pharmacology)
  • Neuroblastoma (metabolism)
  • Pertussis Toxin
  • Tumor Cells, Cultured
  • Virulence Factors, Bordetella (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: